Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1α, and Stat3

Journal of Neurochemistry

Volumn 105, Issue 2, 2008, Pages 324-337

  Santra, Manoranjan ^a   Santra, Sutapa ^a   Zhang, Jing ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Decorin; Epidermal growth factor receptor; Hypoxia inducible factor 1 and signal transducer and activator of transcription 3; Sp1; Vascular endothelial growth factor

Indexed keywords

DECORIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMIN; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT3 PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; GLYCOSYLATION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41849120867     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05134.x     Document Type: Article

References (48)

1. Aozuka Y., Koizumi K., Saitoh Y., Ueda Y., Sakurai H. Saiki I. (2004) Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett. 216, 35 42.
2. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J. Greenberg M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857 868.
3. Chopp M., Zhang Z. G. Jiang Q. (2007) Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38, 827 831. Review.
4. Csordas G., Santra M., Reed C. C., Eichstetter I., McQuillan D. J., Gross D., Nugent M. A., Hajnoczky G. Iozzo R. V. (2000) Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 275, 32879 32887.
5. Datta S. R., Brunet A. Greenberg M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905 2927.
6. Davies J. E., Tang X., Bournat J. C. Davies S. J. (2006) Decorin promotes plasminogen/plasmin expression within acute spinal cord injuries and by adult microglia in vitro. J. Neurotrauma 23, 397 408.
7. Fagel D. M., Ganat Y., Silbereis J., Ebbitt T., Stewart W., Zhang H., Ment L. R. Vaccarino F. M. (2006) Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp. Neurol. 199, 77 91.
8. Fojas de Borja P., Collins N. K., Du P., Azizkhan-Clifford J. Mudryj M. (2001) Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 20, 5737 5747.
9. Geisberg J. V. Struhl K. (2004a) Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucleic Acids Res. 32, e151.
10. Geisberg J. V. Struhl K. (2004b) Cellular stress alters the transcriptional properties of promoter-bound Mot1-TBP complexes. Mol. Cell 14, 479 489.
11. Han I. Kudlow J. E. (1997) Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17, 2550 2558.
12. Iozzo R. V. (1998) Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609 652. Review.
13. Iozzo R. V., Moscatello D. K., McQuillan D. J. Eichstetter I. (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274, 4489 4492.
14. Jarvelainen H. T., Iruela-Arispe M. L., Kinsella M. G., Sandell L. J., Sage E. H. Wight T. N. (1992) Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp. Cell Res. 203, 395 401.
15. Jarvelainen H., Puolakkainen P., Pakkanen S., Brown E. L., Hook M., Iozzo R. V., Sage E. H. Wight T. N. (2006) A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 14, 443 452.
16. Kallmann B. A., Wagner S., Hummel V., Buttmann M., Bayas A., Tonn J. C. Rieckmann P. (2002) Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 16, 589 591.
17. Knobbe C. B., Merlo A. Reifenberger G. (2002) Pten signaling in gliomas. Neuro. Oncol. 4, 196 211. Review.
18. Livak K. J. Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 25, 402 408.
19. Loh Y. H., Wu Q., Chew J. L. et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431 440.
20. Luwor R. B., Lu Y., Li X/., Mendelsohn J. Fan Z. (2005) The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression. Oncogene 24, 4433 4441.
21. Mauviel A., Santra M., Chen Y. Q., Uitto J. Iozzo R. V. (1995) Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J. Biol. Chem. 270, 11692 11700.
22. Mompeo B., Engele J. Spanel-Borowski K. (2003) Endothelial cell influence on dorsal root ganglion cell formation. J. Neurocytol. 32, 123 129.
23. Moscatello D. K., Santra M., Mann D. M., McQuillan D. J., Wong A. J. Iozzo R. V. (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101, 406 412.
24. Nakagami H., Morishita R., Yamamoto K., Taniyama Y., Aoki M., Matsumoto K., Nakamura T., Kaneda Y., Horiuchi M. Ogihara T. (2001) Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37, 581 586.
25. Nelimarkka L., Salminen H., Kuopio T., Nikkari S., Ekfors T., Laine J., Pelliniemi L. Jarvelainen H. (2001) Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am. J. Pathol. 158, 345 353.
26. Pepper M. S. (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104 1117. Review
27. Pore N., Jiang Z., Gupta A., Cerniglia G., Kao G. D. Maity A. (2006) EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. Cancer Res. 66, 3197 3204.
28. Ruggero D. Sonenberg N. (2005) The Akt of translational control. Oncogene 24, 7426 7434.
29. Santra M., Skorski T., Calabretta B., Lattime E. C. Iozzo R. V. (1995) De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA 92, 7016 7020.
30. Santra M., Mann D. M., Mercer E. W., Skorski T., Calabretta B. Iozzo R. V. (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100, 149 157.
31. Santra M., Eichstetter I. Iozzo R. V. (2000) An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem. 275, 35153 35161.
32. Santra M., Reed C. C. Iozzo R. V. (2002) Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J. Biol. Chem. 277, 35671 35681.
33. Santra M., Katakowski M., Zhang R. L., Zhang Z. G., Meng H., Jiang F. Chopp M. (2006a) Protection of adult mouse progenitor cells and human glioma cells by de novo decorin expression in an oxygen- and glucose- deprived cell culture model system. J. Cereb. Blood Flow Metab. 26, 1311 1322.
34. Santra M., Zhang X., Santra S., Jiang F. Chopp M. (2006b) Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells. Cancer Res. 66, 11726 11735.
35. Santra M., Liu X. S., Santra S., Zhang J., Zhang R. L., Zhang Z. G. Chopp M. (2006c) Ectopic expression of doublecortin protects adult rat progenitor cells and human glioma cells from severe oxygen and glucose deprivation. Neuroscience 142, 739 752.
36. Schonherr E., O'Connell B. C., Schittny J., Robenek H., Fastermann D., Fisher L. W., Plenz G., Vischer P., Young M. F. Kresse H. (1999) Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur. J. Cell Biol. 78, 44 55.
37. Schonherr E., Levkau B., Schaefer L., Kresse H. Walsh K. (2001a) Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J. Biol. Chem. 276, 40687 40692.
38. Schonherr E., Schaefer L., O'Connell B. C. Kresse H. (2001b) Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression. J. Cell. Physiol. 187, 37 47.
39. Schonherr E., Sunderkotter C., Schaefer L., Thanos S., Grassel S., Oldberg A., Iozzo R. V., Young M. F. Kresse H. (2004) Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J. Vasc. Res. 41, 499 508.
40. Schonherr E., Sunderkotter C., Iozzo R. V. Schaefer L. (2005) Decorin, a novel player in the insulin-like growth factor system. J. Biol. Chem. 280, 15767 15772.
41. Shen Q., Goderie S. K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K. Temple S. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338 1340.
42. Shi Y. H., Wang Y. X., Bingle L., Gong L. H., Heng W. J., Li Y. Fang W. G. (2005) In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205, 530 536.
43. Ward N. L. Lamanna J. C. (2004) The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol. Res. 26, 870 883.
44. Wurmser A. E., Nakashima K., Summers R. G., Toni N., D'Amour K. A., Lie D. C. Gage F. H. (2004a) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430, 350 356.
45. Wurmser A. E., Palmer T. D. Gage F. H. (2004b) Neuroscience. Cellular interactions in the stem cell niche. Science 304, 1253 1255.
46. Yan J., Jiang J., Lim C. A., Wu Q., Ng H. H. Chin K. C. (2007) BLIMP1 regulates cell growth through repression of p53 transcription. Proc. Natl. Acad. Sci. USA 104, 1841 1846.
47. Yao C., Roderfeld M., Rath T., Roeb E., Bernhagen J. Steffens G. (2006) The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 27, 1608 1616.
48. Zhang Z. G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N. Chopp M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829 838.